MVI makes routine use of external experts to move its research and development (R&D) strategy forward. As part of a carefully developed portfolio review process, MVI has established a Vaccine Science Portfolio Advisory Council (VSPAC), which comprises eminent malaria scientists and vaccinologists who meet at least once a year to provide strategic input and advice on MVI’s portfolio and overall R&D program.

Former members

  • John Adams, PhD, MSc
  • Fred Binka, MBChB, PhD, MPH
  • John Boslego, MD
  • David C. Kaslow, MD
  • Kamini Mendis, MD, PhD, DSc
  • Tom Monath, MD
  • Hassan Mshinda, PhD, MSc
  • Marie Kieny, PhD
  • Rino Rappuoli, PhD
  • David Salisbury, CB, FRCP, FRCPCH, FFPH
  • George Siber, MD
  • Moriya Tsuji, MD, PhD
  • Kathryn Zoon, PhD